Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis-Reference-Cited by-同舟云学术

Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis

Published:2007-02 Issue:2 Volume:3 Page:86-95
ISSN:1745-8382
Container-title:Nature Clinical Practice Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Taylor Ronald P,Lindorfer Margaret A

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/ncprheum0424.pdf

Reference64 articles.

1. Grillo-Lopez A et al. (1999) Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26: 66–73

2. Edwards JCW et al. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350: 2572–2581

3. Gottenberg JE et al. (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64: 913–920

4. Eisenberg R and Albert D (2005) B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2: 1–6

5. Cohen SB et al. (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54: 2793–2806

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differenzialdiagnose und Therapie der Immunthrombozytopenie;DMW - Deutsche Medizinische Wochenschrift;2024-07-16

2. Use of phase plate cryo-EM reveals conformation diversity of therapeutic IgG with 50 kDa Fab fragment resolved below 6 Å;Scientific Reports;2024-06-18

3. Utility of Brainstem Auditory Evoked Response as a Diagnostic Tool and Rituximab as a Treatment for Severe Bickerstaff Brainstem Encephalitis: A Case Report;Cureus;2024-04-10

4. Cancer treatment with biosimilar drugs: A review;Cancer Innovation;2024-04

5. Use of phase plate cryo-EM reveals conformation diversity of therapeutic IgG with 50 kDa Fab fragment resolved below 6 Å;2023-12-22